Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$103.2K
33.84K shares
What this filing means
AUERBACH ALAN H plans to sell 33.84K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $103.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2025ACC: 0001610717-25-000001
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
33.84K
Shares to sell
$103.2K
Approx. market value
353.78K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Unit Grant
Compensation for Services Rendered
3/15/2024
6.58KRestricted Stock Unit Grant
Compensation for Services Rendered
2/12/2024
160.80KRestricted Stock Unit Grant
Compensation for Services Rendered
2/10/2023
186.40KTotal acquired353.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 6.58K | — |
2/12/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 160.80K | — |
2/10/2023 | Restricted Stock Unit Grant Compensation for Services Rendered | 186.40K | — |
| Total | 353.78K | ||
Planned & Completed Dispositions1
NASDAQGSPlanned
Units to sell
33.84K
Market value
$103.2K
1/2/2025
Total
Units
33.84K
Value
$103.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/2/2025 | 33.84K | $103.2K | NASDAQGS | Planned |
| Total | 33.84K | $103.2K | ||